Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 690-694    DOI: 10.12891/ceog4753.2019
Original Research Previous articles | Next articles
Lipid indices in women blood serum before and after the procedure of removal of mature ovarian teratoma
M. Karmowski1, †, K. A. Sobiech2, †, J. Majda3, †, P. Rubisz1, †*(), A. Karmowski1, †, L. Hirnle1, †
1Department of Gynecology and Obstetrics, Wroclaw Medical University, Wrocław, Poland
2Department of Human Biology, University School of Physical Education in Wrocław, Wrocław, Poland
3Department of Laboratory Diagnostics, IV Military Hospital, Wrocław, Poland
Download:  PDF(589KB)  ( 218 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Purpose of Investigation: The aim of this study was to find new markers for detection of ovarian neoplasms. Authors decided to compare the lipid indicies in the blood serum of patients undergoing surgery treatment of mature ovarian teratomas. Lack of data on this subject in accessible literature was a stimulating factor for this study. Materials and Methods: The examinations covered two groups of women, each with 32 persons. Fasting blood serum gained from blood samples was analysed, marking before the surgical procedure, on the 7th day, six and 12 months after the procedure. Correlations between lipid indices changes HDL/TCH, HDL/LDL, and ApoA1/ApoB was analysed with use of Spearman correlation test. Results: In all parameters of the lipid metabolism and lipid indices, similar direction of changes - that is a trend direction, has been observed. Conclusions: Lipid indices showed their usefulness in preoperational monitoring, the effectiveness of treatment, and postoperative monitoring of mature ovarian teratomas.

Key words:  Lipid index      Ovarian neoplasm      Ovarian teratoma      Blood serum      Lipid changes     
Published:  10 October 2019     
*Corresponding Author(s):  P. RUBISZ     E-mail:  piotr.rubisz@gmail.com
About author:  Contributed equally.

Cite this article: 

M. Karmowski, K. A. Sobiech, J. Majda, P. Rubisz, A. Karmowski, L. Hirnle. Lipid indices in women blood serum before and after the procedure of removal of mature ovarian teratoma. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 690-694.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4753.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/690

[1] Sema Karakaş, Cihan Kaya, Sebastian Daniel Schäfer, Mislav Mikuš, Milan Terzic, Bekhzod Abdullaev, Alessandra Andrisani. Fertility-sparing in cancer patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 787-794.
[2] S.H. Park, J. Lim, K.T. Lim, K.H. Choi, S.M. Yoon, H.J. Chung. Ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis, a type of limbic encephalitis: a review of the literature and a case report in korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 774-780.
[3] Y.A. Kim. Mature cystic teratoma of the uterus presenting as an endometrial polyp in a patient with a history of ovarian mature cystic teratoma with gliomatosis peritonei and ovarian endometriosis: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 800-804.
[4] S.Y. Jung, H.Y. Cho, S.H. Lee, S. Lim, K.B. Lee. Pregnancy outcomes of a giant primary ovarian leiomyoma in the first trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 135-138.
[5] Y.-S. Kim, J.-Y. Hwang, T.-H. Kim, E.-G. Lee, H.-H. Lee. Genome-wide association study of recurrent endometriosis related with ovarian cancer[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 553-559.
[6] S. Matsuoka, H. Tsujioka, M. Ando, Y. To, T. Koyanagi, H. Kondo, F. Eguchi. Anti-N-methyl-D-aspartate receptor encephalitis associated with a tiny ovarian teratoma diagnosed by exploratory laparoscopy: report of two cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 305-308.
[7] Xi Yang, Ke Ma, Yiting Meng. Parasitic teratoma in the pouch of Douglas[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 952-956.
[8] S. Yanai, Y. Hashiguchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi. Early operative treatment of anti-N-methyl D-aspartate (anti-NMDA) receptor encephalitis in a patient with ovarian teratoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 819-821.
[9] G. Jalencas, E. González Bosquet, L. Guirado, M. Fernandez Arias, B. Ruiz de Gauna, L. Fiores, M.D. Gómez Roig, J. Callejo. Ovarian mature teratoma: a ten year experience in our institution[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 518-522.
[10] S. Diamantopoulou, K. Sikiotis, J. Panayiotides, D. Kassanos. Serous cystadenoma with massive ovarian edema. A case report and review of the literature.[J]. Clinical and Experimental Obstetrics & Gynecology, 2009, 36(1): 58-61.
[11] M. G. Porpora, D. Pallante, A. Ferro, P. L. Alò, E. V. Cosmi. Asymptomatic struma ovarii: A case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2005, 32(3): 197-198.
[12] M. Varras. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer[J]. Clinical and Experimental Obstetrics & Gynecology, 2004, 31(2): 85-98.
[13] M. Varras, A. Tsikini, D. Polyzos, Ch. Samara, G. Hadjopoulos, Ch. Akrivis. Uterine adnexal torsion: Pathologic and gray-scale ultrasonographic findings[J]. Clinical and Experimental Obstetrics & Gynecology, 2004, 31(1): 34-38.
No Suggested Reading articles found!